Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific Mass Spec User Meetings

Published: Tuesday, October 15, 2013
Last Updated: Tuesday, October 15, 2013
Bookmark and Share
Guest presenters from Harvard Medical School, Stanford, Michigan State University, Pfizer and Bristol Meyers Squibb and other organizations will describe how they apply the latest high resolution accurate mass spectrometry technology to a variety of challenging life science experiments.

Oct. 22, 2013, Somerset, NJ.

• Wilhelm Haas, Massachusetts General Hospital: Transforming Protein Quantitation with Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer
• Josh Coon, University of Wisconsin: NeuCode SILAC and Parallel Reaction Monitoring using the Orbitrap Fusion Tribrid MS
• Gavin Reid, Michigan State University: Mass Spec Strategies for Comprehensive Lipidome Analysis to Identify Lipid Biomarkers of Disease
• Jessy YY Fan, Pfizer: Quantification of Therpeutic Protein Targets using Immunoaffinity and High Resolution Mass Spectrometry
• David Pirman, Pfizer: Monitoring the Metabolic Fate of Biological Substrates by High Resolution Mass Spectrometry

October 22, 2013, Foster City, CA

• Shenheng Guan, University of California, San Francisco: Orbitrap-based Native Mass Spectrometry for Characterization of Large Intact Protein Complexes
• Livia Eberlin, Stanford University: Desorption of Electrospray Ionization Mass Spectrometry Imaging in Biomedical Research
• Christopher Adams, Stanford University: Current State of Structural Proteomics
• Dan McKemie, University of California, Davis: Analysis of Morphine and Morphine Metabolites

October 24,Cambridge, MA.

• Steve Gygi, Harvard Medical School: Transforming Protein Quantitation with Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer
• Anna Merrill, University of Wisconsin: NeuCode SILAC and Parallel Reaction Monitoring using the Orbitrap Fusion Tribrid MS
• Jack Henion Quintiles: High Resolution MS for the Quantitative Determination of Guanfacine in Dried Plasma Spots Derived from Molecular Filtration of Whole Blood


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,100+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific to Acquire Life Technologies Corporation
The definitive agreement will see Thermo Fisher will acquire Life Technologies for $76.00 in cash per fully diluted common share or approximately $13.6 billion.
Monday, April 15, 2013
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Vitamin A May Help Improve Pancreatic Cancer Chemotherapy
The addition of high doses of a form of vitamin A could help make chemotherapy more successful in treating pancreatic cancer, according to an early study by Queen Mary University of London (QMUL).
Breakthrough Approach to Breast Cancer Treatment
Scripps scientists have designed a drug candidate that decreases growth of breast cancer cells.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
Making Injectable Medicine Safer
Researchers remove excess additives from drugs, which could reduce the odds of serious allergic reactions and other side effects.
An Old-New Weapon Against Emerging Chikungunya Virus
Researchers utilize existing drugs to interfere with host factors required for replication of Chikungunya virus.
Brazilian Zika Virus Strain Causes Birth Defects in Experimental Models
First direct experimental proof of causal effect, researchers say.
'Kidney on a Chip' Facilitates Safer Drug Dosing
University of Michigan researchers have used a "kidney on a chip" device to mimic the flow of medication through human kidneys and measure its effect on kidney cells.
Ketamine Metabolism Lifts Depression
NIH-funded team finds rapid-acting, non-addicting agent in mouse study.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!